|
CENPJ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78879133727605E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26818563930919E-12 |
| Normal-vs-Stage2 |
3.98947541668804E-12 |
| Normal-vs-Stage3 |
1.77602377249286E-12 |
| Normal-vs-Stage4 |
1.62614366416847E-12 |
| Stage1-vs-Stage2 |
7.939200E-01 |
| Stage1-vs-Stage3 |
3.328800E-01 |
| Stage1-vs-Stage4 |
1.464660E-03 |
| Stage2-vs-Stage3 |
6.701600E-01 |
| Stage2-vs-Stage4 |
7.431900E-02 |
| Stage3-vs-Stage4 |
1.315240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69497749169523E-12 |
| Normal-vs-AfricanAmerican |
5.39519540154743E-11 |
| Normal-vs-Asian |
1.62360014321905E-10 |
| Caucasian-vs-AfricanAmerican |
6.489800E-01 |
| Caucasian-vs-Asian |
2.016400E-01 |
| AfricanAmerican-vs-Asian |
6.637600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69642078162724E-13 |
| Normal-vs-Female |
1.89626092605977E-13 |
| Male-vs-Female |
8.714000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.16195941757269E-12 |
| Normal-vs-Age(41-60Yrs) |
1.91247018221929E-12 |
| Normal-vs-Age(61-80Yrs) |
1.4432899320127E-14 |
| Normal-vs-Age(81-100Yrs) |
2.36309971590742E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.848200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.871900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.487420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.042800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.100200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.901000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.85009999999731E-05 |
| Classical-VS-Follicular |
6.491500E-02 |
| Classical-VS-Other |
9.698200E-01 |
| Classical-VS-Normal |
1.86373139143825E-12 |
| Tall-VS-Follicular |
1.63860000002014E-06 |
| Tall-VS-Other |
1.784450E-01 |
| Tall-VS-Normal |
1.62492241884138E-12 |
| Follicular-VS-Other |
4.849400E-01 |
| Follicular-VS-Normal |
5.06129582689141E-11 |
| Other-VS-Normal |
3.82139999977049E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13686837721616E-13 |
| Normal-vs-N1 |
6.88660017900133E-10 |
| N0-vs-N1 |
7.277800E-01 |
|
|
